• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Lange Clinical Neurology, 11th Edition

Lange Clinical Neurology, 11th Edition

9781260458350
Print on demand. This item has an extended shipping time. The typical delivery time is 4-8 weeks.
328,80 zł
312,36 zł Zniżka 16,44 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 312,36 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis
The clearest, most concise coverage of one of the most complex topics in medicine—updated with the latest advances in the field

Clinical Neurology, Eleventh Edition, provides a comprehensive overview of basic and clinical neurology in a concise, digestible format. It links clinical neuroscience to current approaches for accurately diagnosing and effectively treating neurologic disorders. Covering all the advances in molecular biology and genetics, this popular guide emphasizes history-taking and neurologic examination as the cornerstones of diagnosis. All information is thoroughly up-to-date and presented as a practice-oriented approach to neurology based on the patients presenting symptoms or signs.

Features:: 

• 350+ tables and figures
• Chapter outlines providing overview of each topic
• Treatment protocols reflecting the most recent advances in the field
• Step-by-step review of the neurologic examination


Szczegóły produktu
82142
9781260458350
9781260458350

Opis

Rok wydania
2020
Numer wydania
11
Oprawa
miękka foliowana
Liczba stron
464
Wymiary (mm)
188 x 231
Waga (g)
923
  • Chapter 1. NeurologicHistory & Examination

    Neurologic examination ofsphincter function

    Chapter 2. InvestigativeStudies

    Neuromuscular imaging studies

    Update on ultrasonography forneuromuscular diagnosis

    Chapter 3. Coma

    Introduction

    Role of prefrontal cortex in consciousness

    Causes of coma

    Spontaneous intracranialhypotension as a cause of coma

    Persistent vegetative state

    New imaging insights intopersistent vegetative & minimally conscious states

    Treatment of traumatic vegetative &minimally conscious states with amantadine

    Chapter 4. ConfusionalStates

    Drugs

    Serotonin syndrome

    Electrolyte disorders

    Antidepressant-inducedhyponatremia

    Endocrine & metabolic disorders

    Mechanisms of impairedhypoglycemia sensing in treated diabetes

    Nutritional disorders

    Furosemide-induced thiaminedeficiency

    Organ system failure

    ICU delirium

    Postoperative cognitivedysfunction

    Meningitis, encephalitis & sepsis

    Mechanism of N. meningitidis vascular spread

    Dysregulated host inflammatoryresponse in tuberculous meningitis

    CSF findings in HIV-infectedpatients with tuberculous meningitis

    Tick-borne encephalitis & (re-emergent)yellow fever

    Nipah virus encephalitis

    Updated diagnostic testing forviral encephalitis

    New recommendation on empiricaltreatment of toxoplasmosis in AIDS

    Fexinidazole for treatment of Africantrypanosomiasis

    Mechanism of meningeal invasion inleukemia

    Chapter 5. Dementia& Amnestic Disorders

    Introduction

    Somatic neuronal mutations in aging and neurodegeneration

    Differential diagnosis

    Biomarker-based diagnostic algorithms for dementia syndromes

    Neurodegenerativeproteinopathies

    Tau folding in Alzheimer vs. Pickdisease

    Tau-disrupted nucleocytoplasmictransport in Alzheimer disease pathogenesis

    Contrasting mechanisms ofaggregate toxicity in neurodegeneration

    Herpes simplex virus infection andAlzheimer disease

    Inflammation in Alzheimer diseasepathogenesis

    Meningeal lymphatics (glymphatics)in Alzheimer disease pathogenesis

    Blood pressure and risk of Alzheimerdisease

    Relation between epilepsy anddementia

    Exercise training in dementia

    Sex differences in Alzheimerdisease

    Spatial navigation deficits asearly signs of Alzheimer disease

    Subjective cognitive decline in relationto Alzheimer disease

    Update on biomarkers for Alzheimerdisease

    Concomitant neurodegenerativeproteinopathies

    Update on clinical trials oftreatments for Alzheimer disease (eg, solanezumab, verubecestat)

    Clinical and pathologicalcorrelates of primary progressive aphasia variants

    New consensus guidelines fordiagnosis & treatment of dementia with Lewy bodies

    Skin prions in Creutzfeldt-Jakobdisease infectivity and diagnosis

    Other cerebral disorders

    Shunting response to gait vs. dementia in normal pressurehydrocephalus

    Normal pressure hydrocephalus vs.neurodegenerative ventriculomegaly

    Mild traumatic brain injury & dementia

    Systemic disorders

    Subclinical hyperthyroidism &dementia

    Pseudodementia

    Features of memory impairment in depression

    Amnestic syndromes

    Update on antibody-mediatedencephalitis antigens & treatment

    Chapter 6. Headache& Facial Pain

    Migraine

    Triptans, SSRIs & serotoninsyndrome

    CGRP receptor-blocking monoclonalantibodies (eg, erenumab, fremanezumab)

    Prochlorperazine plusdiphenhydramine vs. hydromorphone for IV migraine therapy

    Vagus nerve stimulation as acute therapyfor migraine

    Reconsideration of medicationoveruse headache

    Update on sustained release drugs

    Safety of migraine drugs in pregnancyand breast-feeding

    Cluster headache

           CGRPreceptor-blocking monoclonal antibodies

    Giant cell arteritis

    Tocilizumab for treatment ofgiant-cell arteritis

    Intracranial mass

    Molecular classification of braintumors

    Subventricular zone origin ofglioblastoma multiforme

    Nivolumab plus ipilimumab formelanoma brain metastases

    Chapter 7. Neuro-OphthalmicDisorders

    Update on imaging of optic nervedisorders (optical coherence tomography)

    Nonarteritic anterior ischemic optic neuropathy inobstructive sleep apnea

    Erectile dysfunction drugs & nonarteritic anterior ischemicoptic neuropathy

    Updated consensus management ofpseudotumor cerebri

    Update on imaging of giant cellarteritis (ultrasound, MRI, PET)

    Charles Bonnet syndrome incortical blindness

    Chapter 8. Disordersof Equilibrium

    New Figure: Sites of involvement in peripheral vestibular disorders

    Peripheral vestibular disorders

    Self-treatment of benign paroxysmal positional vertigo

    Cerebellar & central vestibulardisorders

    Autoimmune septin-5 cerebellarataxia

    Cerebellar histiocytosis

    Sensory ataxias

    Nonataxic symptoms in FriedreichAtaxia

    Chapter 9. MotorDisorders

    Spinal cord disorders

    Ibudilast for treatment of progressivemultiple sclerosis

    Simvastatin for cognitivedysfunction in secondary progressivemultiple sclerosis

    Clinical differentiation oftransverse myelitis etiologies

    Circumferential resectioncord-compressing tumors (vs. decompressive laminectomy)

    Anterior horn cell disorders

    Kinesin family member 5A (KIF5A) mutationsassociated with ALS

    Edaravone for treatment of ALS

    Nusinersen for treatment oflater-onset spinal muscular atrophy

    Disorders of peripheral nerve

    Critical illness neuromyopathy(updating critical illness polyneuropathy) & management

    Disorders of neuromuscular transmission

    Bilevel positive airway pressure(BiPAP) for myasthenic crisis

    Tensilon®replaced by Enlon® (both edrophonium) for myasthenia testing

    Eculizumab for treatment ofmyasthenia gravis

    Chapter 10. SensoryDisorders

    New Table: Pharmacologic Treatment of Pain

    Approach to diagnosis

    Neuropathic itch: causes &treatment

    Polyneuropathies

    Guillain-Barresyndrome associated with bone and digestive organ surgery

    Autoantibodies in chronic inflammatory demyelinatingpolyradiculoneuropathy

    Polyneuropathy with monoclonal gammopathy of uncertain significance

    Fluoroquinolone-induced polyneuropathy

    Patisiran treatment of hereditarytransthyretin-mediated amyloidosis

    Chapter 11. MovementDisorders

    Parkinsonism

    LRRK2 activation in idiopathic Parkinson disease

    Postural tremor subtypes in Parkinson disease

    Light therapy treatment of Parkinsondisease

    Chapter 12. Seizures& Syncope

    Seizures

    Update on sustained release drugs

    Safety of anticonvulsant drugs inpregnancy and breast-feeding

    Newly approved anticonvulsantdrugs: clobazam, eslicarbazepine, perampanel,

    Cannabidiol for treatment of Lennox-Gastaut& Dravet syndromes

    Hypothermia not associated with betteroutcome in status epilepticus

    No increased risk of seizures withattention-deficit disorder medications

    Syncope

    Relative efficacy of nonpharmacologicinterventions for orthostatic hypotension

    Chapter 13. Stroke

    Approach to diagnosis

    Updated epidemiology ofcerebrovascular disease

    Focal cerebral ischemia—approach to diagnosis

    Temporal trends in ischemic stroke subtypes

    Five-year risk of stroke after TIAor minor ischemic stroke (2018 study)

    Factors associated with emergencyroom misdiagnosis of stroke

    Focal cerebral ischemia—pathophysiology

    Skull bone marrow in post-strokeinflammatory response

    Focal cerebral ischemia—etiology

    New perspectives on cerebral smallvessel disease

    Preeclampsia, posterior reversible encephalopathy syndrome, and stroke

    Late-life systolic and diastolicblood pressure and risk of stroke

    Intra-ictal blood pressure and poststroke cognitive impairment

    Blood lipid profiles in relationto stroke subtypes

    Psychological stress as a risk factor for stroke

    Sepsis as a risk factor for stroke

    Update on genetics, epidemiology& management of cerebrovascular fibromuscular dysplasia

    Update on ischemic stroke incancer patients and its treatment

    Stroke risk in occult and manifest cancers

    Biopsy vs. imaging findings in primaryCNS vasculitis

    Update on patent foramen ovaleclosure for cryptogenic stroke

    Effects of sex and aura on strokerisk in migraine

    Role of paradoxical embolism instroke in migraineurs

    Presentations and treatment updatein cerebral venous and sinus thrombosis

    Focal cerebral ischemia—prevention & treatment

    LDL cholesterol target levels forsecondary stroke prevention

    Stroke prevention in the veryelderly

    Hypercoagulability workup for nonatheroscleroticischemic stroke

    Aspirin for primary stroke preventionin diabetes mellitus

    Diagnosis & management of theantiphospholipid syndrome in stroke prevention

    Embolic stroke after leftventricular endocardial ablation

    American Heart Association 2018 guidelines for management of acuteischemic stroke

    Aspirin ± clopidogrel for acute ischemic strokeand TIA

    Betrixaban vs. enoxaparin forstroke prophylaxis in hospitalized patients

    Ezetimibe for stroke prevention inacute coronary syndrome

    Rivaroxaban ±aspirin for secondary stroke prevention

    Rivaroxaban vs.aspirin for secondary prevention after cryptogenic stroke

    Andexanet alfa for reversing bleeding from factor Xa inhibitor treatment

    Timing for initiating statin therapy after acute ischemic stroke

    Warfarin vs. vitamin K antagonists for embolic stroke prevention inatrial fibrillation

    Reappraisal of endarterectomy forasymptomatic carotid stenosis

    Leukoaraiosis & risk of hemorrhage after thrombolysis

    Tenecteplase versus alteplase thrombolysis before thrombectomy forischemic stroke

    Safety of thrombolysis in patients on non–vitamin K antagonist oralanticoagulants

    Time to endovascular treatment and outcome in acute ischemic stroke

    Endovascular thrombectomy 6-24hours after stroke onset

    MRI-guided thrombolysis for stroke withunknown time of onset

    Endovascular therapy for distalintracranial occlusions

    Effect of intravenous thrombolysisprior to mechanical thrombectomy on stroke outcome

    Effect of interhospital transferon stroke outcome after thrombectomy

    EmboTrap thrombectomy for acuteischemic stroke from large-vessel occlusion

    Conscious sedation vs. localanesthesia for endovascular treatment of stroke

    Cervical nerve transfer for limbparalysis after stroke

    Focal cerebral ischemia—complications & rehabilitation

    Mechanisms of cardiac complications after stroke

    Hyperglycemia & post-strokeinfection

    Microbiological etiologies of pneumonia complicating stroke

    Post-stroke fatigue and itstreatment

    Post-stroke anxiety subtypes

    Long-term risk of post-strokeseizures

    Mechanisms of motor compensationafter stroke

    Robotic exosuits for strokerehabilitation

    Intracerebral hemorrhage

    Etiology of deep vs. superficial cerebellar hemorrhage

    Update on etiology & outcome of perimesencephalic hemorrhage

    Risk of intracerebral hemorrhage from warfarin vs. direct oralanticoagulants

    Effects of statins on incidence of intracerebral and subarachnoidhemorrhage

    Blood pressure target to prevent brain ischemia after intracerebralhemorrhage

    Genetics of intracranial aneurysms

    Medical vs. interventional therapy for unruptured brain AVMs: results ofrandomized trial

    Spetzler–Martin grading scale & treatment of brain AVMs

    Update on genetics and bleedingrisk of cranial cavernous malformations

    Global cerebral ischemia

    Early hyperoxia and neurologicalfunction after cardiac arrest

    Epinephrine & neurological outcomeafter cardiac arrest

     

Komentarze (0)